Illustration: Aïda Amer/Axios

The pharmaceutical industry's lobbyists will really have to work for those millions once Congress comes back from its August recess.

Driving the news: Drug pricing will likely dominate the fall agenda in Congress.

  • The bipartisan leadership of the Senate Finance Committee — Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) — released their long-awaited drug pricing bill yesterday. Finance is slated to mark it up on Thursday.
  • House Democrats, meanwhile, are planning to roll out their own bill after the recess — meaning both chambers could have their bills on the floor in September.

On the substance, the bipartisan Senate bill is pretty far-reaching, in the sense that it reaches into many parts of the system. The House bill may end up being more aggressive on its big-ticket items, though.

  • The Senate measure would cap price increases in Medicare Part D and Part B, put a cap on seniors' out-of-pocket costs, and reshape Part D more broadly to deal with some of the program's backwards incentives.

What they're saying: PhRMA, the industry's leading trade organization, said yesterday that the bill "fails to meet the fundamental test of providing meaningful relief at the pharmacy counter for the vast majority of seniors," while the White House signaled its support.

My thought bubble: Everyone's written a million stories about congressional Republicans being pulled between President Trump and some traditionally conservative idea or interest group.

  • But none of those traditional allies have brought as much campaign cash to the table as pharma. That tension could be real this time.
  • Even so, with a bipartisan framework to start and Trump's blessing on top of it, the industry will face a daunting challenge trying to stop the Senate from passing anything serious.
  • And if House Speaker Nancy Pelosi can get the progressives in her caucus on board, then we'd be back to the dynamic I mentioned yesterday: testing the bounds of Pelosi's and Trump's ability and willingness to make a deal.

Go deeper

Updated 9 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 5 a.m. ET: 12,910,357 — Total deaths: 569,128 — Total recoveries — 7,116,957Map.
  2. U.S.: Total confirmed cases as of 5 a.m. ET: 3,304,942— Total deaths: 135,205 — Total recoveries: 1,006,326 — Total tested: 40,282,176Map.
  3. States: Florida smashes single-day record for new cases with over 15,000 — NYC reports zero deaths for first time since pandemic hit.
  4. Public health: Ex-FDA chief projects "apex" of South's curve in 2-3 weeks — Testing czar: Lockdowns in hotspots "should be on the table"
  5. Education: Betsy DeVos says schools that don't reopen shouldn't get federal funds — Pelosi accuses Trump of "messing with the health of our children."
Column / Harder Line

How Europe’s green pandemic recovery will push the rest of the world

Illustration: Sarah Grillo/Axios

Europe, long the most progressive continent when it comes to tackling climate change, is doubling down on this ambition to revive pandemic-ravaged economies.

Why it matters: The European Union is the world’s third-largest emitting region after the U.S. and China, but it’s not just that. These plans will push global corporate behavior and prod other governments by creating either templates to follow or protectionist battles (or both).

Scoop: How the White House is trying to trap leakers

Illustration: Sarah Grillo/Axios

President Trump's chief of staff, Mark Meadows, has told several White House staffers he's fed specific nuggets of information to suspected leakers to see if they pass them on to reporters — a trap that would confirm his suspicions. "Meadows told me he was doing that," said one former White House official. "I don't know if it ever worked."

Why it matters: This hunt for leakers has put some White House staffers on edge, with multiple officials telling Axios that Meadows has been unusually vocal about his tactics. So far, he's caught only one person, for a minor leak.